Ann: Final Phase IIb AIPAC clinical trial results for Efti in MBC, page-12

Following on from this, I've had a good think about this tonight and the more I collect my thoughts about this, the happier I am and the more reasonable the result seems. Thoughts:

• AIPAC results were never going to surprise on the upside. Prelim data was already out and they hit the exact goal I would have like them to hit, clear indication that Low Monocyte group achieved not only a statistically significant result, but in fact improved on the previous results in every way possible.
• Clear to me that IMMP was bought up on the expectation that the it would be a blockbuster result, this was never going to happen in a million years with AIPAC, they already released their prelim results! They achieved as large a delta as you can hope for with the results overnight.
• Selling on IMMP was clearly the recent buying pressure clearly unwinding.
• I wish I had the time this morning to load up at open but unfortunately stuck in meetings, the fact that it traded back down to the placement price was an absolute gimme.
• I don't think IMM mgmt pumped up anything, they clearly announced what they were doing via facts and the speculation was driven by those who have a shorter investment horizon than most.

I wish I bought on open today but will reassess whether I buy IMMP tonight.

The story in my view has only gotten better.